Clinical Trial Update: Adoptive Immunotherapy for CMV Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating adoptive immunotherapy for CMV disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cmv Disease

Drugs mentioned

• Adoptive Immunotherapy for CMV Disease

Snippet

Sponsor: Hadassah Medical Organization | Conditions: CMV Disease | Phase 1, Phase 2 | Status: WITHDRAWN